YorkBridge Wealth Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-4,306
| Closed | -$2.08M | – | 244 |
|
|
2020
Q4 | $2.08M | Buy |
4,306
+214
| +5% | +$103K | 0.7% | 42 |
|
|
2020
Q3 | $2.29M | Buy |
4,092
+413
| +11% | +$231K | 0.96% | 30 |
|
|
2020
Q2 | $2.29M | Buy |
3,679
+525
| +17% | +$327K | 1.05% | 27 |
|
|
2020
Q1 | $1.54M | Buy |
3,154
+5
| +0.2% | +$2.44K | 0.95% | 33 |
|
|
2019
Q4 | $1.18M | Sell |
3,149
-86
| -3% | -$32.3K | 0.54% | 56 |
|
|
2019
Q3 | $897K | Buy |
3,235
+279
| +9% | +$77.4K | 0.45% | 63 |
|
|
2019
Q2 | $925K | Buy |
2,956
+28
| +1% | +$8.76K | 0.41% | 62 |
|
|
2019
Q1 | $1.2M | Buy |
2,928
+266
| +10% | +$109K | 0.55% | 54 |
|
|
2018
Q4 | $994K | Sell |
2,662
-260
| -9% | -$97.1K | 0.53% | 54 |
|
|
2018
Q3 | $1.15M | Buy |
2,922
+27
| +0.9% | +$10.6K | 0.53% | 54 |
|
|
2018
Q2 | $999K | Buy |
2,895
+353
| +14% | +$122K | 0.44% | 62 |
|
|
2018
Q1 | $826K | Buy |
2,542
+97
| +4% | +$31.5K | 0.38% | 71 |
|
|
2017
Q4 | $812K | Buy |
2,445
+18
| +0.7% | +$5.98K | 0.39% | 69 |
|
|
2017
Q3 | $1.09M | Sell |
2,427
-406
| -14% | -$182K | 0.56% | 50 |
|
|
2017
Q2 | $1.38M | Buy |
2,833
+136
| +5% | +$66.3K | 0.73% | 36 |
|
|
2017
Q1 | $1.08M | Buy |
2,697
+798
| +42% | +$321K | 0.57% | 48 |
|
|
2016
Q4 | $756K | Buy |
+1,899
| New | +$756K | 0.45% | 63 |
|